Trasis
Ruben Veronesi is currently working as a Scientist in Radiochemistry at Trasis since August 2023. Prior to this, Ruben was a Doctoral Student at Alma Mater Studiorum - Università di Bologna from November 2019 to November 2022, and a Visiting PHD Student at the University of Regensburg from October 2021 to August 2022. Ruben holds a PhD in Chemistry from Alma Mater Studiorum – Università di Bologna, completed between November 2019 and March 2023. Additionally, Ruben has a Master of Science in Synthetic Methodologies and Bio-Organic Chemistry, completed between October 2017 and July 2019, and a Bachelor of Science in Chemistry and Materials Chemistry, completed between October 2014 and July 2017.
Trasis
At Trasis our primary focus is allowing the medical community to access new radiolabelled therapeutic and diagnostic substances easier and faster. To this end, we design, manufacture, sell and support high performance synthesizers, dose preparation equipment, their shielding and accessories. We also develop customized synthetic methods and instruments. We can provide GMP Active Pharmaceutical Ingredients (API) and assist our customers with their regulatory affairs. Our proven radiopharmaceutical expertise, coupled with our high end instruments allow us to provide fully integrated solutions for an effective tracer production and faster transition from drug development to marketing authorization. Our equipment is used worldwide in nuclear medicine departments, research centers, radiopharmaceutical production facilities and pharmaceutical companies.